Q3 2025 Cardiff Lexington Corp Earnings Call Transcript

Nov 14, 2025 / 02:00 PM GMT

Release Date Price: $3.9

Transcript 10-Q

Key Points

Positve

Cardiff Lexington Corp (CDIX) reported strong triple-digit revenue growth, with total revenue increasing to $3.1 million in Q3 2025 from $1.4 million in Q3 2024.
The company's gross margin improved significantly to 62.4% in Q3 2025, compared to 26.2% in Q3 2024.
Cardiff Lexington Corp (CDIX) achieved adjusted EBITDA profitability, with $1.9 million in adjusted EBITDA for the nine months ended September 30, 2025.
The company operates in a recession-resistant sector, providing orthopedic care, which remains in demand regardless of economic conditions.
Cardiff Lexington Corp (CDIX) has a high collection rate of over 95% due to its payment model involving automotive insurance settlements and private payments.

Negative

The company reported a net loss of $1.1 million in Q3 2025, although this was an improvement over the $2 million net loss in Q3 2024.
Interest expenses increased to approximately $1.8 million in Q3 2025, up from $1.4 million in the prior year period.
The company's Nova Ortho and Spine locations are operating at only 35% capacity due to working capital limits and lack of capitalization.
Total liabilities increased to $22.6 million as of September 30, 2025, from $16.3 million at December 31, 2024, primarily due to an increased line of credit.
The company faces high barriers to entry and operates in a highly fragmented market, which may pose challenges for expansion and consolidation.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CDIX.PK - Cardiff Lexington Corp
Q3 2025 Cardiff Lexington Corp Earnings Call
Nov 14, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone and thank you for participating in today's conference call to discuss Cardiff Lexington's financial results for the third quarter ended September 30, 2025. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.

If anyone requires operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the call over to Walter Frank of IMS Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.